SavedAdd your journal

Journals / Acta Medica / 2021 / Cilt: 52 - Sayı: 3

COVID-19 Associated Refractory Immune Thrombocytopenia: A Case Report

Pusem PATIR
Pages
254–255
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We report here the patient with refractory immune thrombocytopenia associated with COVID‐19 infection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We report here the patient with refractory immune thrombocytopenia associated with COVID‐19 infection.
📊
Key Findings & Data:We report here the patient with refractory immune thrombocytopenia associated with COVID‐19 infection.
💡
Conclusion & Impact:We report here the patient with refractory immune thrombocytopenia associated with COVID‐19 infection.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We report here the patient with refractory immune thrombocytopenia associated with COVID‐19 infection.

🔖

Cite This Article

PATIR, P. (2022). COVID-19 Associated Refractory Immune Thrombocytopenia: A Case Report. Acta Medica, Cilt: 52 - Sayı: 3, 254–255. https://ajindex.com/articles/427533

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study. Platelets. 2020; 31(4): 490-496
  2. Zulfiqar AA, Lorenzo-Villalba N, Hassler P, et al. Immune thrombocytopenic purpura in a patient with COVID-19. N Engl J Med. 2020; 382(18): e43
  3. Cooper N, Ghanima W. Immune Thrombocytopenia. N Engl J Med. 2019; 381: 945-955
  4. Swinkels M, Rijkers M, Voorberg J, et al. Emerging Concepts in Immune Thrombocytopenia. Front Immunol. 2018; 9: 880
  5. Cao W, Liu X, Bai T, et al. High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019. Open Forum Infect Dis. 2020; 7(3): ofaa102
  6. Bhattacharjee S, Banerjee M. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review. SN Compr Clin Med. 2020; 19: 1-11
  7. Jansen AJG, Swart RM, te Boekhorst PAW. Thrombopoietinreceptor agonists for immunethrombocytopenia. N Engl J Med. 2011; 365: 2240-2241.